(Q37418071)

20 August 2017

1 reference

title

Oral inhalation therapy: meeting the challenge of developing more patient-appropriate devices (English)

1 reference

20 August 2017

Jolyon P Mitchell

1

1 reference

20 August 2017

Mark W Nagel

series ordinal

2

1 reference

20 August 2017

publication date

1 March 2009

1 reference

Expert Review of Medical Devices

20 August 2017

published in

1 reference

20 August 2017

volume

6

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

147-155

1 reference

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Comparison of drug delivery from conventional versus "Venturi" nebulizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Development of dry powder inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Dry powder aerosol delivery systems: current and future research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Importance of inhaler devices in the management of airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Valved holding chambers (VHCs) for use with pressurised metered-dose inhalers (pMDIs): a review of causes of inconsistent medication delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Design of facemasks for delivery of aerosol-based medication via pressurized metered dose inhaler with valved holding chamber: key issues that affect performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Inhaler devices in infants and children: challenges and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Metered dose inhalers: a need for dose counters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Dose counting and the use of pressurized metered-dose inhalers: running on empty

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Successful use of DPI systems in asthmatic patients--key parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Adaptive Aerosol Delivery (AAD) technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

The AERX aerosol delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Pulmonary insulin administration using the AERx insulin diabetes system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Miniaturized nebulization catheters: a new approach for delivery of defined aerosol doses to the rat lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Development of a microinstillation model of inhalation exposure to assess lung injury following exposure to toxic chemicals and nerve agents in Guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Feasibility and safety of targeted cisplatin delivery to a select lung lobe in dogs via the AeroProbe intracorporeal nebulization catheter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

A miniaturized nebulization catheter for improved gene delivery to the mouse lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheter

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Dry powder inhalers (DPIs)--a review of device reliability and innovation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Inhaling medicines: delivering drugs to the body through the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Trying to deliver aerosols to upset children is a thankless task

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Role of inhaler competence and contrivance in "difficult asthma".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

Peptide and protein drug delivery to and into tumors: challenges and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.6.2.147

21 January 2018

Identifiers

DOI

10.1586/17434440.6.2.147

1 reference

20 August 2017

1 reference